243 related articles for article (PubMed ID: 35008248)
1. CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug Target.
Malik S; Westcott JM; Brekken RA; Burrows FJ
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008248
[TBL] [Abstract][Full Text] [Related]
2. CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma.
Morita T; Kodama Y; Shiokawa M; Kuriyama K; Marui S; Kuwada T; Sogabe Y; Matsumori T; Kakiuchi N; Tomono T; Mima A; Ueda T; Tsuda M; Yamauchi Y; Nishikawa Y; Sakuma Y; Ota Y; Maruno T; Uza N; Nagasawa T; Chiba T; Seno H
Cancer Res; 2020 Oct; 80(19):4058-4070. PubMed ID: 32606001
[TBL] [Abstract][Full Text] [Related]
3. The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets.
Roberto M; Arrivi G; Di Civita MA; Barchiesi G; Pilozzi E; Marchetti P; Santini D; Mazzuca F; Tomao S
Front Oncol; 2023; 13():1154581. PubMed ID: 37035150
[TBL] [Abstract][Full Text] [Related]
4. Early pancreatic cancer lesions suppress pain through CXCL12-mediated chemoattraction of Schwann cells.
Demir IE; Kujundzic K; Pfitzinger PL; Saricaoglu ÖC; Teller S; Kehl T; Reyes CM; Ertl LS; Miao Z; Schall TJ; Tieftrunk E; Haller B; Diakopoulos KN; Kurkowski MU; Lesina M; Krüger A; Algül H; Friess H; Ceyhan GO
Proc Natl Acad Sci U S A; 2017 Jan; 114(1):E85-E94. PubMed ID: 27986950
[TBL] [Abstract][Full Text] [Related]
5. The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives.
Wu Y; Zhang C; Jiang K; Werner J; Bazhin AV; D'Haese JG
Front Oncol; 2020; 10():621937. PubMed ID: 33520728
[TBL] [Abstract][Full Text] [Related]
6. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
Liu H; Shi Y; Qian F
Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881
[TBL] [Abstract][Full Text] [Related]
7. Tumor Stroma as a Therapeutic Target for Pancreatic Ductal Adenocarcinoma.
Lee DU; Han BS; Jung KH; Hong SS
Biomol Ther (Seoul); 2024 May; 32(3):281-290. PubMed ID: 38590092
[TBL] [Abstract][Full Text] [Related]
8. Interactions between Cancer-Associated Fibroblasts and T Cells in the Pancreatic Tumor Microenvironment and the Role of Chemokines.
Gorchs L; Kaipe H
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34203869
[TBL] [Abstract][Full Text] [Related]
9. Stellate Cells Aid Growth-Permissive Metabolic Reprogramming and Promote Gemcitabine Chemoresistance in Pancreatic Cancer.
Amrutkar M; Gladhaug IP
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33546284
[TBL] [Abstract][Full Text] [Related]
10. NF-κB Dependent Chemokine Signaling in Pancreatic Cancer.
Geismann C; Schäfer H; Gundlach JP; Hauser C; Egberts JH; Schneider G; Arlt A
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31561620
[TBL] [Abstract][Full Text] [Related]
11. Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches.
Carvalho TMA; Di Molfetta D; Greco MR; Koltai T; Alfarouk KO; Reshkin SJ; Cardone RA
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885243
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic Signaling.
Roy I; McAllister DM; Gorse E; Dixon K; Piper CT; Zimmerman NP; Getschman AE; Tsai S; Engle DD; Evans DB; Volkman BF; Kalyanaraman B; Dwinell MB
Cancer Res; 2015 Sep; 75(17):3529-42. PubMed ID: 26330165
[TBL] [Abstract][Full Text] [Related]
13. The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer.
Sun Q; Zhang B; Hu Q; Qin Y; Xu W; Liu W; Yu X; Xu J
Theranostics; 2018; 8(18):5072-5087. PubMed ID: 30429887
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
[TBL] [Abstract][Full Text] [Related]
15. The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions.
Herting CJ; Karpovsky I; Lesinski GB
Cancer Metastasis Rev; 2021 Sep; 40(3):675-689. PubMed ID: 34591240
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblasts in pancreatic adenocarcinoma.
Pan B; Liao Q; Niu Z; Zhou L; Zhao Y
Future Oncol; 2015 Sep; 11(18):2603-10. PubMed ID: 26284509
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis in the Pancreatic Cancer Tumor Microenvironment-The Double-Edged Sword of Cancer-Associated Fibroblasts.
Pfeifer E; Burchell JM; Dazzi F; Sarker D; Beatson R
Cells; 2021 Jul; 10(7):. PubMed ID: 34359823
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic Tumor Microenvironment.
Wang K; He H
Adv Exp Med Biol; 2020; 1296():243-257. PubMed ID: 34185297
[TBL] [Abstract][Full Text] [Related]
19. Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy.
Hofschröer V; Najder K; Rugi M; Bouazzi R; Cozzolino M; Arcangeli A; Panyi G; Schwab A
Front Pharmacol; 2020; 11():586599. PubMed ID: 33841132
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
